Analysising the Marginal Bone Loss, Torque and Implant Stability Placed in Bone and Tissue Level … (NCT07288606) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Analysising the Marginal Bone Loss, Torque and Implant Stability Placed in Bone and Tissue Level Dental Implants
Spain20 participantsStarted 2022-12-02
Plain-language summary
It is a prospective clinical study to compare two implants of the same brand of a similar design for implantation \[either at the bone tissue level or at the soft tissue level\], in order to evaluate the marginal bone loss of each dental implant in mm. 96 patients will be analyzed (an expected N of 48 per group, hoping to reach 100 implants per arm).
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients of both sexes, over 18 years of age, who need dental implant placement for prosthetic rehabilitation. Whether partially or completely in both the maxilla and the mandible.
* Patients with residual alveolar ridge with at least 8 mm of bone height and 4 mm of width.
* Patients must have the ability to understand and decide when voluntarily signing the informed consent before carrying out any intervention related to the study.
* Patients who, after being informed about the objectives and procedures of the research, agree will sign the informed consent form. And they are ready to carry out the different study visits.
Exclusion Criteria:
* Patients with uncontrolled systemic diseases (ASA ≥ III).
* Patients who do not have 8mm bone height and/or 4mm width
* Patients who require bone regeneration
* Patients with severe periodontal disease or acute pericoronitis.
* Pregnant and breastfeeding women.
* Patients with Deficient or Inadequate Oral Hygiene.
* Patients with severe bruxism.
* Patients taking bisphosphonates or other antiresority medications.
* Smoker of more than 10 cigarettes/day.
* Patients with uncontrolled diabetes mellitus.
* Psychiatric illnesses or unrealistic expectations.
* Immunodepressed or immunocompromised patient.